Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like Cardinal Health Unloads China Biz to Shanghai Pharma in $1.2B Deal November 14, 2017 <b>VenatoRx Pharma</b> Banks $42 Million to Advance Antibiotics Pipeline July 24, 2017 5 Biotechs Quietly Hitting Unusual Volumes Right Now June 22, 2017
